Dr. Robert Hariri is the Co-Founder of IPMC, Founder and CEO of Celgene Cellular Therapeutics, and Co-Founder of Human Longevity. Dr. Hariri was awarded the Thomas Alva Edison Award in 2007 for his discovery of placental stem cells and again in 2011 for engineering tissues and organs from stem cells.
Dr. Andrew von Eschenbach was the former Commissioner of the US Food and Drug Adminstration (FDA) from 2006 to 2009. He was previously the 12th director of the National Cancer Institute and currently serves on the Board of Directors of BioTime and as a Director of Viamet Pharmaceuticals.
John Sculley is an American businessman, entrepreneur and investor in high-tech startups. Sculley was Vice-President(1970-1977) and President(1977-1983) of Pepsi-Cola, until he became CEO of Apple Inc., which he held until leaving in 1993. He is currently the Chairman of PeopleTicker and Vice-Chairman of RxAdvance.
Dr. Leming Shi is a distinguished professor at the School of Pharmacy and the School of Life Sciences of Fudan University in Shanghai, where he established the Center for Pharmacogenomics. He was a Principal Investigator at the US FDA from 2003 to 2012. Dr. Shi is a guest faculty at the US FDA and an adjunct professor of medicine at the University of Arkansas for Medical Sciences.
John Nosta is an American critical thinker with a background in science and marketing, most notable for his work in the field of digital health. He is the founder of NostaLab, and from 2012 to 2014, he wrote a health- and technology-themed blog for Forbes called Health Critical. He is also a member of and strategic advisor to the Google Health Advisory Board.
Jay Young Chun, MD, PhD, is Vice President of Atlantic NeuroSurgical Specialists and Director of Neurotrauma at Morristown Memorial Medical Center in Morristown, New Jersey. Dr. Chun is one of few surgeons on the East Coast who is adept at surgery with the CyberKnife®.
Dr. Henry H. Ji, Ph.D., co-founded Sorrento Therapeutics, Inc. (STI) in January 2006 and has been its CEO and President since September 2012. He has more than 18 years of biotechnology and biopharmaceutical experience. In 2002, he founded BioVintage, Inc. and served as its President since 2002.
Dr. Xiaokui Zhang is a Senior Director at Celgene Cellular Therapeutics and has fifteen years of expertise in leading discovery, reaserch and development in the biopharmaceutical industry to advance research stage programs into early clinical development for immunology, innuno-oncology and hematology applications.